The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes

Table 2

Five-year survival of the eight ER/PR/HER2 subtypes.

ER/PR/HER2		%	5-year survival	95% CI
ER+/PR+/HER2−	83,169	58.09%	94.95%	(94.86%, 95.12%)
ER+/PR+/HER2+	13,293	9.28%	92.00%	(91.73%, 92.52%)
ER+/PR−/HER2−	13,363	9.33%	89.58%	(89.27%, 90.17%)
ER+/PR−/HER2+	4,535	3.17%	87.87%	(87.31%, 88.96%)
ER−/PR+/HER2−	1,131	0.79%	83.68%	(82.46%, 86.08%)
ER−/PR+/HER2+	539	0.38%	85.53%	(83.85%, 88.83%)
ER−/PR−/HER2−	18,299	12.78%	78.78%	(78.44%, 79.45%)
ER−/PR−/HER2+	8,855	6.18%	81.11%	(80.65%, 82.02%)
Total	143,184

Survival for all subtypes statistically significantly worse (Log-Rank test ) than the ER+/PR+/HER2− subtype.